Price History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹1,356 Cr | ₹1,507.3 Cr | ₹1,643.8 Cr | ₹2,151.2 Cr |
| Net Profit | ₹197.2 Cr | ₹196.7 Cr | ₹258.4 Cr | ₹126.7 Cr |
| EPS | — | ₹9.68 | ₹12.72 | ₹6.24 |
| Operating Profit | ₹375.3 Cr | ₹360.3 Cr | ₹425.2 Cr | ₹337.6 Cr |
Peer Comparison
HospitalPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| APOLLOHOSP | Apollo Hospitals Enterprise Limited | ₹8,498.00 | +0.06% |
| MAXHEALTH | Max Healthcare Institute Limited | ₹1,012.45 | +0.28% |
| FORTIS | Fortis Healthcare Limited | ₹990.35 | +0.14% |
| ASTERDM | Aster DM Healthcare Limited | ₹814.95 | +0.15% |
| MEDANTA | Global Health Limited | ₹1,235.10 | +0.49% |
| KIMS | Krishna Institute of Medical Sciences Limited | ₹785.10 | +2.57% |
| AGARWALEYE | Dr. Agarwal's Health Care Limited | ₹439.75 | +0.08% |
| RAINBOW | Rainbow Childrens Medicare Limited | ₹1,365.00 | +1.87% |
| PARKHOSPS | Park Medi World Limited | ₹274.60 | +0.49% |
| HCG | Healthcare Global Enterprises Limited | ₹630.50 | +0.17% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 01 Aug 2025 | Dividend - Rs 4.50 Per Share | DIVIDEND |
| 02 Aug 2024 | Dividend - Rs 4 Per Share | DIVIDEND |
| 07 Jul 2023 | Dividend - Rs 2.50 Per Share | DIVIDEND |
| 22 Aug 2022 | Dividend - Rs 1 Per Share | DIVIDEND |
| 11 Mar 2020 | Interim Dividend - Re 1 Per Share | INTERIM_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for NH
View AllNarayana Hrudayalaya jumps 6% after Q4FY26 results, dividend announcement
For the January to March quarter of FY26, Narayana Hrudayalaya delivered record revenue and profit growth, driven by strong operational performance across geographies.

Six pharma stocks that should be on your radar today over various news triggers
It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail:
Narayana Hrudayalaya consolidated net profit rises 13.52% in the March 2026 quarter
Sales rise 75.80% to Rs 2593.81 crore
